UA92932C2 - Veterinary agent for treatment and prevention of endometrites - Google Patents

Veterinary agent for treatment and prevention of endometrites

Info

Publication number
UA92932C2
UA92932C2 UAA200811093A UAA200811093A UA92932C2 UA 92932 C2 UA92932 C2 UA 92932C2 UA A200811093 A UAA200811093 A UA A200811093A UA A200811093 A UAA200811093 A UA A200811093A UA 92932 C2 UA92932 C2 UA 92932C2
Authority
UA
Ukraine
Prior art keywords
prevention
treatment
endometrites
veterinary agent
veterinary
Prior art date
Application number
UAA200811093A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Наталия Владиславовна Тоцкая
Максим Владимирович Руденко
Татьяна Григорьевна Ярных
Original Assignee
Наталия Владиславовна Тоцкая
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Наталия Владиславовна Тоцкая filed Critical Наталия Владиславовна Тоцкая
Priority to UAA200811093A priority Critical patent/UA92932C2/en
Publication of UA92932C2 publication Critical patent/UA92932C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to veterinary and concerns an agent for treatment and prevention of postpartum genital infections, including endometritis in cattle containing oxytetracyclin hydrochloride and excipients.
UAA200811093A 2008-09-12 2008-09-12 Veterinary agent for treatment and prevention of endometrites UA92932C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA200811093A UA92932C2 (en) 2008-09-12 2008-09-12 Veterinary agent for treatment and prevention of endometrites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200811093A UA92932C2 (en) 2008-09-12 2008-09-12 Veterinary agent for treatment and prevention of endometrites

Publications (1)

Publication Number Publication Date
UA92932C2 true UA92932C2 (en) 2010-12-27

Family

ID=50737931

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200811093A UA92932C2 (en) 2008-09-12 2008-09-12 Veterinary agent for treatment and prevention of endometrites

Country Status (1)

Country Link
UA (1) UA92932C2 (en)

Similar Documents

Publication Publication Date Title
TN2009000292A1 (en) Formulations for cancer treatment
MX2022009942A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
SG10201902429PA (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
BR112014031914A2 (en) soluble estradiol capsule for vaginal insertion
MX2023008408A (en) Antisense compositions and methods of making and using same.
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
MX2009006704A (en) New compounds.
UA103614C2 (en) Medicinal composition for treating hepatic cancer which comprises a kinase inhibitor. combined with glypican 3 antibody
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
MY150518A (en) Substituted gamma lactams as therapeutic agents
IN2013MU03583A (en)
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
MX2010002735A (en) Titration package for neramexane and its use in the treatment of an inner ear disorder.
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
MX2010009624A (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1.
MX2013004906A (en) Novel specific hcv ns3 protease inhibitors.
GB201014391D0 (en) Drug composition and its use in therapy
MX2016005092A (en) Vaginal inserted estradiol pharmaceutical compositons and methods.
MX2014011218A (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections.
EP2124554A4 (en) Compositions and methods for the treatment of cancer
EP2329819A4 (en) Pharmaceutical composition for use in treating sexually transmitted infections
UA92932C2 (en) Veterinary agent for treatment and prevention of endometrites
MX2017013453A (en) Use of (4-hydroxy-2-methyl-1,1-dioxido-2h-benzo[e][1,2]thiazine-3 -yl)(naphthalene-2-yl) methanone in the prevention and/or treatment of non-alcoholic steatohepatitis.
MX2012004282A (en) Pharmaceutical compositions.